DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Effect of Race on Gonadotropin Responses

Phase 1

Completed

Conditions: Premenopause
Healthy

Interventions: Drug: Estradiol steroid infusion
Drug: Progesterone steroid infusion

First Posted Date: 2007-04-04

Last Posted Date: 2017-07-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT00455962

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

Phase 4

Completed

Conditions: Major Depressive Disorder
Alcohol Abuse
Alcohol Dependence

Interventions: Drug: acamprosate
Drug: escitalopram
Behavioral: Medical management
Drug: Placebo

First Posted Date: 2007-03-27

Last Posted Date: 2012-07-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT00452543

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding

Completed

Conditions: Precancerous Condition

First Posted Date: 2007-03-09

Last Posted Date: 2017-01-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 170

Registration Number: NCT00445653

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Harvard School of Public Health, Boston, Massachusetts, United States

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Procedure: Proton Beam Radiation
Drug: Capecitabine

First Posted Date: 2007-02-22

Last Posted Date: 2019-01-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00438256

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Phase 1

Terminated

Conditions: Metabolic Syndrome

Interventions: Drug: Zoladex
Other: Placebo
Drug: Testosterone gel
Drug: Anastrozole Pill

First Posted Date: 2007-02-22

Last Posted Date: 2017-04-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 66

Registration Number: NCT00438321

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Dasatinib in Relapsed Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Dasatinib

First Posted Date: 2007-02-22

Last Posted Date: 2017-12-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT00438854

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

A Clinical Trial of Splinting for DeQuervain's Tenosynovitis

Completed

Conditions: DeQuervain's Tenosynovitis

First Posted Date: 2007-02-22

Last Posted Date: 2017-06-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 83

Registration Number: NCT00438191

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

The Safety and Efficacy of Recombinant Human Prolactin

Phase 2

Completed

Conditions: Healthy

Interventions: Drug: Recombinant Human Prolactin

First Posted Date: 2007-02-22

Last Posted Date: 2018-01-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 21

Registration Number: NCT00438490

Locations: 🇺🇸
Corrine Welt, Boston, Massachusetts, United States

Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Lanthanum Carbonate
Dietary Supplement: Low Phosphorus Diet
Dietary Supplement: Unrestricted Phosphorus Diet
Drug: Placebo

First Posted Date: 2007-02-22

Last Posted Date: 2011-09-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT00438932

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Comparison of Occupational Therapy and Home Exercises for Adults With Operatively Treated Distal Radius Fractures

Not Applicable

Completed

Conditions: Distal Radius Fractures

Interventions: Other: Independent Excercises
Other: Occupational Therapy

First Posted Date: 2007-02-22

Last Posted Date: 2012-06-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 94

Registration Number: NCT00438750

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy